Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion

British Journal of Pharmacology

Volumn 171, Issue 11, 2014, Pages 2726-2738

  Skovsted, G F ^a,b   Kruse, L S ^a   Larsen, R ^a   Pedersen, A F ^a   Trautner, S ^c   Sheykhzade, M ^b   Edvinsson, L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

coronary artery; endothelin; endothelin receptor; sarafotoxin 6c; vascular smooth muscle

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR TYPE A; ENDOTHELIN RECEPTOR TYPE B; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SARAFOTOXIN 6C; UNCLASSIFIED DRUG; CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE; SARAFOTOXINS S6; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY OCCLUSION; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REPERFUSION INJURY; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ANIMAL; CORONARY BLOOD VESSEL; LIGATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; CORONARY VESSELS; ENDOTHELIN A RECEPTOR ANTAGONISTS; ENDOTHELIN B RECEPTOR ANTAGONISTS; LIGATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, SMOOTH MUSCLE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; UP-REGULATION; VASOCONSTRICTION; VIPER VENOMS;

EID: 84900528401     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12606     Document Type: Article

References (52)

1. Adlbrecht C, Andreas M, Redwan B, Distelmaier K, Mascherbauer J, Kaider A, et al. (2012). Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study. EuroIntervention 7: 1386-1395.
2. Adner M, Cantera L, Ehlert F, Nilsson L, Edvinsson L, (1996). Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 119: 1159-1166.
3. Adner M, Geary GG, Edvinsson L, (1998). Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol Scand 163: 121-129.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
5. Alonso D, Radomski MW, (2003). The nitric oxide-endothelin-1 connection. Heart Fail Rev 8: 107-115.
6. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
7. Bacon CR, Cary NR, Davenport AP, (1996). Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res 79: 794-801.
8. de Beer VJ, de Graaff HJ, Hoekstra M, Duncker DJ, Merkus D, (2010). Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender. Am J Physiol Heart Circ Physiol 298: H1976-H1985.
9. Climent B, Fernandez N, Sanz E, Sanchez A, Monge L, Garcia-Villalon AL, et al. (2005). Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 524: 102-110.
10. Dagassan PH, Breu V, Clozel M, Kunzli A, Vogt P, Turina M, et al. (1996). Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol 27: 147-153.
11. Domenech R, Macho P, Gonzalez R, Huidobro-Toro JP, (1991). Effect of endothelin on total and regional coronary resistance and on myocardial contractility. Eur J Pharmacol 192: 409-416.
12. Garcia-Villalon AL, Amezquita YM, Monge L, Fernandez N, Salcedo A, Dieguez G, (2008). Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion. Vascul Pharmacol 48: 109-114.
13. Halcox JP, Nour KR, Zalos G, Quyyumi AA, (2001). Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade. Circ Res 89: 969-976.
14. Haynes WG, Webb DJ, (1994). Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852-854.
15. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86: 2863-2867.
16. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
17. Kloog Y, Ambar I, Sokolovsky M, Kochva E, Wollberg Z, Bdolah A, (1988). Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 242: 268-270.
18. Korzick DH, Muller-Delp JM, Dougherty P, Heaps CL, Bowles DK, Krick KK, (2005). Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C. Cardiovasc Res 66: 384-392.
19. Krishnan U, Win W, Fisher M, (2010). First report of the successful use of bosentan in refractory vasospastic angina. Cardiology 116: 26-28.
20. Larkin SW, Clarke JG, Keogh BE, Araujo L, Rhodes C, Davies GJ, et al. (1989). Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol 64: 956-958.
21. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr, (1991). Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001.
22. Lockowandt U, Liska J, Franco-Cereceda A, (2001). Short ischemia causes endothelial dysfunction in porcine coronary vessels in an in vivo model. Ann Thorac Surg 71: 265-269.
23. MacCarthy PA, Pegge NC, Prendergast BD, Shah AM, Groves PH, (2001). The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J Am Coll Cardiol 37: 137-143.
24. Maguire JJ, Davenport AP, (1995). ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 115: 191-197.
25. Maguire JJ, Davenport AP, (2000). No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery disease. J Cardiovasc Pharmacol 36: S380-S381.
26. Martinez-Revelles S, Caracuel L, Marquez-Martin A, Dantas A, Oliver E, D'Ocon P, et al. (2012). Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion. Br J Pharmacol 165: 937-950.
27. Matsuyama K, Yasue H, Okumura K, Saito Y, Nakao K, Shirakami G, et al. (1991). Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am J Cardiol 68: 991-995.
28. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
29. Merkus D, Houweling B, van den Meiracker AH, Boomsma F, Duncker DJ, (2005). Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol 288: H871-H880.
30. Neubauer S, Zimmermann S, Hirsch A, Pulzer F, Tian R, Bauer W, et al. (1991). Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol 23: 1397-1409.
31. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Buhler FR, (1990). Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 168: 1303-1310.
32. Saetrum OO, Adner M, Gulbenkian S, Edvinsson L, (1994). Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 23: 576-583.
33. Saetrum OO, Adner M, Peters TH, Xu CB, Stavenow L, Gulbenkian S, et al. (2001). Endocardial expression and functional characterization of endothelin-1. Mol Cell Biochem 224: 151-158.
34. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
35. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF, (1994). Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208.
36. Skovsted GF, Pedersen AF, Larsen R, Sheykhzade M, Edvinsson L, (2012). Rapid functional upregulation of vasocontractile endothelin ET(B) receptors in rat coronary arteries. Life Sci 91: 593-599.
37. Stewart DJ, Kubac G, Costello KB, Cernacek P, (1991). Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18: 38-43.
38. Suzuki T, Kumazaki T, Mitsui Y, (1993). Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun 191: 823-830.
39. Takamura M, Parent R, Cernacek P, Lavallee M, (2000). Influence of dual ET(A)/ET(B)-receptor blockade on coronary responses to treadmill exercise in dogs. J Appl Physiol 89: 2041-2048.
40. Thorin E, Parent R, Ming Z, Lavallee M, (1999). Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans. Am J Physiol 277: H524-H532.
41. Toyo-Oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, et al. (1991). Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483.
42. Vermeltfoort IA, Raijmakers PG, Kamphuisen PW, (2009). Improved myocardial perfusion preceding clinical response on bosentan treatment for coronary vasospasm. Acta Cardiol 64: 415-417.
43. Wackenfors A, Emilson M, Ingemansson R, Hortobagyi T, Szok D, Tajti J, et al. (2004). Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries. Eur J Pharmacol 484: 103-109.
44. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, et al. (1992). Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068.
45. Wang J, Zeballos GA, Kaley G, Hintze TH, (1991). Dilation and constriction of large coronary arteries in conscious dogs by endothelin. Am J Physiol 261: H1379-H1386.
46. Watts JA, Chapat S, Johnson DE, Janis RA, (1992). Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts. J Cardiovasc Pharmacol 19: 929-936.
47. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, et al. (1994). Endothelin in human congestive heart failure. Circulation 89: 1580-1586.
48. Wendel M, Kummer W, Knels L, Schmeck J, Koch T, (2005). Muscular ETB receptors develop postnatally and are differentially distributed in specific segments of the rat vasculature. J Histochem Cytochem 53: 187-196.
49. Wendel-Wellner M, Noll T, Konig P, Schmeck J, Koch T, Kummer W, (2002). Cellular localization of the endothelin receptor subtypes ET(A) and ET(B) in the rat heart and their differential expression in coronary arteries, veins, and capillaries. Histochem Cell Biol 118: 361-369.
50. Yanagisawa M, Kurihara H, Kimura S, Goto K, Masaki T, (1988a). A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens Suppl 6: S188-S191.
51. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. (1988b). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
52. Zouridakis EG, Schwartzman R, Garcia-Moll X, Cox ID, Fredericks S, Holt DW, et al. (2001). Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J 22: 1578-1584.